Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ultralife (ULBI) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to $33.8 million.

  • Ultralife's Cost of Revenue rose 2495.19% to $33.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.0 million, marking a year-over-year increase of 1633.22%. This contributed to the annual value of $122.1 million for FY2024, which is 225.88% up from last year.
  • Latest data reveals that Ultralife reported Cost of Revenue of $33.8 million as of Q3 2025, which was up 2495.19% from $37.0 million recorded in Q2 2025.
  • Over the past 5 years, Ultralife's Cost of Revenue peaked at $38.0 million during Q1 2025, and registered a low of $19.0 million during Q1 2021.
  • Over the past 4 years, Ultralife's median Cost of Revenue value was $31.4 million (recorded in 2024), while the average stood at $29.9 million.
  • In the last 5 years, Ultralife's Cost of Revenue plummeted by 909.34% in 2024 and then skyrocketed by 2495.19% in 2025.
  • Ultralife's Cost of Revenue (Quarter) stood at $19.5 million in 2021, then soared by 69.95% to $33.1 million in 2023, then rose by 0.32% to $33.3 million in 2024, then grew by 1.5% to $33.8 million in 2025.
  • Its Cost of Revenue stands at $33.8 million for Q3 2025, versus $37.0 million for Q2 2025 and $38.0 million for Q1 2025.